🤩 Why Don't Antidepressants Work for Postpartum Depression?

For a long time, postpartum depression was mistakenly considered a type of regular depression. But research from Tufts University and UCLA has shown that it's actually a separate condition with different neurobiology.

After childbirth, levels of neurosteroids—especially allopregnanolone—drop sharply. In some women, this disrupts the function of the brain's "inhibitory" GABA receptors and stress responses. That's why standard antidepressants, which target serotonin, don't work in about half of cases—they "ignore" this specific aspect.

💊 A breakthrough came with zuranolone, developed by Sage Therapeutics and approved in the U.S. in 2023. This synthetic neurosteroid replenishes what's missing and helps the brain restore disrupted emotion-regulation circuits. Patients can feel better within days—a result that standard antidepressants can't achieve.

For clinical trial participant Kristina Leos, it was like "coming out of a fog" after months of suffering, she says. Before that, Leos had tried several standard antidepressant regimens, none of which helped.

🤱 Research and the success of zuranolone have convinced the medical community that postpartum depression should be treated as a separate illness. But perhaps even more importantly, this new class of medication may help thousands of women regain their sense of connection to their babies and the world around them.

@hiaimediaen